{"nct_id":"NCT06161571","title":"A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-06","start_date":"2023-11-10","start_date_type":"ACTUAL","primary_completion_date":"2026-04","primary_completion_date_type":"ESTIMATED","completion_date":"2026-10","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AKRO"]}